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http:WHAT THIS PAPER ADDS
Perineural catheters, placed alongside the transected sciatic nerve (for transfermoral amputations) or tibial
nerve (for transtibial amputations), have been used to provide targeted local anaesthetic during the post-
operative period. Various studies have suggested this may reduce postoperative pain, opioid use, and long-term
phantom limb pain. This systematic review and meta-analysis demonstrated that postoperative opioid con-
sumption is approximately halved, without affecting immediate postoperative pain, mortality, long-term
phantom limb or stump pain. However, the quality of included papers is generally low, and further research
is required to conﬁrm these ﬁndings.Objective: The aim of this systematic review and meta-analysis was to evaluate the effects of using an
intraoperatively placed perineural catheter (PNC) with a postoperative local anaesthetic infusion on immediate
and long-term outcomes after lower limb amputation.
Methods: A systematic review of key electronic journal databases was undertaken from inception to January
2015. Studies comparing PNC use with either a control, or no PNC, were included. Meta-analysis was performed
for postoperative opioid use, pain scores, mortality, and long-term incidence of stump and phantom limb pain.
Sensitivity analysis was performed for opioid use. Quality of evidence was assessed using the GRADE system.
Results: Seven studies reporting on 416 patients undergoing lower limb amputation with PNC usage (n ¼ 199) or
not (n ¼ 217) were included. Approximately 60% were transtibial amputations PNC use reduced postoperative
opioid consumption (standardised mean difference: 0.59, 95% CI 1.10 to 0.07, p ¼ .03), maintained on
sensitivity analysis for large (p¼ .03) and high-quality (p¼ .003) studies, but wasmarginally lost (p¼ .06) on studies
enrolling patients with peripheral arterial disease only. PNC treatment did not affect postoperative pain scores
(p ¼ .48), in-hospital mortality (p ¼ .77), phantom limb pain (p ¼ .28) or stump pain (p ¼ .37). GRADE quality of
evidence for all outcomes was very low.
Conclusion: There is poor-quality evidence that PNC usage signiﬁcantly reduces opioid consumption following
lower limb amputation, without affecting other short- or long-term outcomes. Well-performed randomised
studies are required.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Major lower limb amputation remains one of the highest
mortality procedures performed in the UK.1 Any interven-
tion to reduce morbidity or mortality is therefore high on
the agenda for vascular surgeons.2 Improving the manage-
ment of postoperative pain in such a high-risk population
would potentially reduce morbidity associated with the
stress response to surgery, and minimise opioid use.2,3
Immediate postoperative pain management commonly
involves epidural or intravenous patient controlled analgesia
242 D.C. Bosanquet et al.(PCA), which are both reliant on opioid-based agents. The
pharmacokinetics of opioids are altered with increasing age,
deteriorating renal function, and polypharmacy;4 attributes
commonly encountered in patients with peripheral arterial
disease (PAD). This potentially leads to adverse drug effects
and interactions. Opioid use is associated with the develop-
ment of postoperative side effects such as nausea, vomiting,
respiratory depression, drowsiness, and delirium, ofwhich the
latter is known to contribute to increased rates of mortality,
reduced functional ability, and longer lengths of hospital stay.5
Phantom limb pain occurs in up to 83% of patients,6,7 and
is known to impair quality of life, impede rehabilitation,8,9
delay psychosocial adjustment,10 and reduce the chance of
return to employment.11 Factors thought to increase post-
operative phantom limb pain include acute postoperative
pain,12 pre-amputation pain,12 noxious intraoperative inputs
and female sex.13e15 Although many pharmacological agents
are available for treatment of phantom limb pain, their ef-
ﬁcacy is variable,16 and better or alternative postoperative
analgesia may prevent hyperplastic peripheral changes and
central neural sensitisation.17,18
The American Society of Anesthesiologists recommends
using multimodal analgesic strategies for managing post-
operative pain.3 This includes the use of opioid-sparing
agents (such as nonsteroidal anti-inﬂammatory drugs, or
acetaminophen), anticonvulsants, and other adjuncts to
reduce pain. One such adjunct is the use of a perineural
catheter (PNC), inserted at the time of surgery to provide a
continuous infusion of local anaesthetic for up to 7 days
postoperatively. First described for amputees by Malwer
et al. in 1991,19 the PNC is inserted adjacent to either the
sciatic nerve for above-knee amputations (AKAs) or the
tibial nerve for below-knee amputations (BKAs), and has
been used as a method of reducing both immediate post-
operative and stump/phantom limb pain. However, data are
conﬂicting as to its efﬁcacy for both short- and long-term
outcomes, and utilisation of this treatment modality varies.
The aim of this systematic review and meta-analysis was
to evaluate the effect of PNCs on immediate postoperative
opioid use and pain, postoperative mortality, and long-term
phantom limb and stump pain in patients undergoing lower
limb amputation.
METHODS
Data sources, search strategy, and selection criteria
The Cochrane collaboration speciﬁed protocol20 was utilised
for this systematic review, which is reported as per the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement for the conduct of
meta-analyses of interventional studies.21 The following
sources were searched without date restrictions: PubMed,
Embase via OVID, the Cochrane Library Database, and the
Current Controlled Trials register. The search strategy,
including MeSH terms utilised, was drafted and reﬁned by
two authors (DCB and CT, online supplement 1). An
extensive search was also conducted of articles to be
included in the analysis using the “Related Articles” functionin PubMed, and reference lists checked for other papers
suitable for inclusion. In addition, the European Journal of
Vascular and Endovascular Surgery, British Journal of Sur-
gery, and Journal of Vascular Surgery websites were
searched individually. There was no search restriction based
on language. The last search date was January 14, 2015.
Outcomes were captured when given in two or more
included papers. When papers were suitable for inclusion,
but presented non-abstractable data for included outcomes,
the corresponding authors were contacted for further data.
Randomised controlled trials (RCTs), cohort studies, and
case series detailing adult patients undergoing major
(hindquarter, transfemoral, through-knee, or transtibial)
lower limb amputation were suitable for inclusion. All
included papers utilised a cohort of patients with an
intraoperative placement of a PNC for a postoperative
infusion of a local anaesthetic (intervention group),
compared with either a placebo control (i.e. containing
normal saline), or alternative anaesthetic regimen without a
PNC (control group). Studies detailing nerve catheters
placed distant to the site of the operation (i.e. transgluteal
sciatic nerve catheters placed under ultrasound guidance),
and those giving a single intraoperative perineural injection
of local anaesthetic without a PNC, were excluded.Data extraction, outcome measures, and assessment of
study quality
A data abstraction proforma was designed by one author
(DCB) and piloted before reﬁnement from all data abstrac-
tors (DCB, JCDG, CT). Data abstraction (DCB and JCDG) and
assessment of methodological quality (DCB, AS) was per-
formed independently by two authors with reference to the
senior author (CT) on matters of disagreement. Extracted
demographic and baseline data included: ﬁrst author, year of
study, study type (RCT, cohort, or quasi-experimental) and
design (including whether retrospective or prospective,
single or multiple centres, and if consecutive patients were
enrolled), number of patients, primary anaesthetic given to
both intervention and control groups, local anaesthetic used
in the treatment group, and study quality as assessed using
the Downs and Black score.22 This checklist is used to score
both RCTs and observational studies for scientiﬁc rigor, and
thus permits quality comparisons between these study
types. It scores studies on ﬁve methodological criteria:
reporting (10 questions, 11 points), external validity (3
questions, 3 points), bias (7 questions, 7 points), confound-
ing (6 questions, 8 points) and power (2 questions, 5 points),
with a maximum score of 34.
The outcome measures collected were:
1. Postoperative opioid consumption;
2. Postoperative pain;
3. Postoperative mortality;
4. Phantom limb pain (pain experienced where the limb
used to exist) incidence at follow-up; and
5. Stump pain (pain localised to the residual portion of the
limb) incidence at follow-up
Perineural catheters after lower limb amputations 243Statistical analysis and evidence rating
Review Manager version 5.2.6 was used for meta-analysis
(RevMan; Nordic Cochrane Centre, Copenhagen,
Denmark). A random-effects (Mantel-Haenszel) model was
used for dichotomous data using odds ratio (OR) as the
summary statistic, and reported with 95% conﬁdence in-
tervals (CI), and an inverse-variance random-effects model
was used for continuous data using standard mean differ-
ence (SMD) as the summary statistic, and reported with
95% CIs. Continuous data presented as a median and range
were transformed to a mean and standard deviation (SD)
using the methodology described by Hozo et al.23 Missing
SDs required for meta-analysis were imputed as per
Cochrane recommendations,20 for which the means were
used as SDs. Heterogeneity was assessed using an I2
calculation.
Sensitivity analyses were performed for studies enrolling
vascular patients alone, larger studies (>50 patients in to-
tal) and high-quality studies (D&B scores of greater than
17). It was impossible to perform sensitivity analysis for
RCTs comparing PNC using either local anaesthetic or pla-
cebo control as only one paper used this methodology,19 or
to compare outcomes at different levels of amputation
(AKA versus BKA) as data were not abstractable in this
format.
The Grading of Recommendations Assessment, Devel-
opment, and Evaluation (GRADE) system was used to rate
the quality of evidence and strength of recommendation, as
per Cochrane collaboration recommendation.24 Quality is
assessed by evaluating: risk of bias, indirectness of evi-
dence, heterogeneity, imprecision of results and publication
bias, and is ranked “high,” “moderate,” “low,” or “very low.”
RCTs by deﬁnition, have a “high” quality of evidence, while
cohort studies have a “low” quality of evidence prior to
further quality assessment. Outcomes derived from equal
numbers of “high” and “low” grade papers are considered
to have a “moderate” level of evidence prior to further
quality assessment. The presence of one or more serious
limitations results in sequential downgrading of evidence.RESULTS
Paper search and selection process
The literature search yielded a total of 2196 papers, of
which 38 (including four conference proceedings) were
retrieved for full evaluation. Seven papers met the inclusion
criteria and were included in the review (Fig. 1).15,19,25e29
Excluded papers of note included four series of PNC use
but without a comparator,30e33 ﬁve series detailing nerve
catheters placed distant to the operative site (e.g. to the
sciatic nerve under ultrasound guidance),34e38 ﬁve case
reports,39e43 two series detailing upper limb amputations
alone or where lower limb data were not abstractable
separately,28,44 three protocols,45e47 and one of a peri-
neural injection of local anaesthetic without catheter.48 A
further abstract was suitable for inclusion according to the
methodology, but gave no data for abstraction.49 Repeatedattempts to contact the authors for further data for evalu-
ation were met with no response. The remaining ten papers
reviewed either did not insert a PNC (n ¼ 6) or placed PNCs
postoperatively (n ¼ 4). A total of 416 patients undergoing
lower limb amputation with PNC usage (n ¼ 199) or not
(n ¼ 217) were therefore included.Study design and baseline characteristics
Baseline study characteristics are detailed in Table 1. Downs
and Black scores ranged from 3 to 23 (median 11) out of a
maximum of 34. Two were prospective RCTs15,28 and the
rest were observational studies. Two included patients with
neoplastic pathologies either exclusively,29 or in combina-
tion with patients with PAD.19 Patients in three papers were
well matched with regards to baseline demographics,15,25,26
while signiﬁcant differences in either co-morbidities or type
of amputations performed were noted in two27,29 (no data
for two). Data on amputation level were given in all but one
paper,25 with approximately 60% being BKAs. Anaesthetic
regimens for both the treatment and control groups
included GA (62% of cases where reported), epidural (17%),
and spinal anaesthetic (21%). Six studies used 0.25e0.5%
bupivacaine alone as the local anaesthetic, while one used
0.25% bupivacane, 0.2% ropivacaine, and 1% lignocaine.25
All papers used a continuous infusion of local anaesthetic
postoperatively for the treatment group, except for two
which used a combination of continuous infusion and
bolused local anaesthetic.19,29 PNCs remained in place for a
weighted mean of 3.3 days postoperatively.Outcomes
Postoperative opioid consumption and pain. All papers
gave data on postoperative opioid use, which was given as
morphine sulphate equivalents (calculated using opioid
conversion tables),50 except for two where morphine use
alone was documented.27,28 Seventy-two hour post-
operative use was given in all but one paper, which gave
overall postoperative morphine use.27 Meta-analysis
showed that PNC use was associated with a signiﬁcant
reduction in postoperative opioid use (SMD 0.59, 95%
CI 1.10 to 0.07, p ¼ .03, I2 ¼ 79%, Table 2, Fig. 2). This
effect was maintained on sensitivity analysis for large
studies (p ¼ .03) and high-quality studies (p ¼ .003), but
was lost, albeit marginally, for patients with PAD alone
(p ¼ .06). GRADE quality of evidence was very low (Table 3).
Two papers captured postoperative pain, assessed using
a visual analogue scale (VAS)15 or verbal rating scale (VRS)25
(both scored 0e10), which have been shown to give com-
parable scores suitable for pooled analysis.51 Treatment
with a PNC did not alter pain scores compared with control
(SMD 0.53, 95% CI 0.93 to 1.98, p ¼ .48, I2 ¼ 92%,
Table 2). Sensitivity analyses could not be performed
because of a lack of studies. GRADE quality of evidence was
very low (Table 3).
Postoperative mortality. In-hospital postoperative mortality
was evaluated by two papers, and was equivalent between
Figure 1. PRISMA graph detailing search results.
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3.07, p ¼ .77, I2 ¼ 38%, Table 2). Sensitivity analyses could
not be performed because of a lack of studies. GRADE
quality of evidence was very low (Table 3).
Phantom limb and stump pain incidence at follow-up.
Long-term follow-up and evaluation of phantom limb pain
was available for three studies (101 patients, weighted
mean follow-up time: 14.6 months). No difference was
found between the treatment and control groups (OR 0.49,
95% CI 0.14 to 1.76, p ¼ .28, I2 ¼ 18%, Table 2). Two papers
(37 patients, weighted mean follow-up time: 14.6 months)
found no difference in the incidence of stump pain between
treatment and control group (OR 0.50, 95% CI 0.11 to 2.33,
p ¼ .37, I2 ¼ 0%, Table 2). Sensitivity analyses could not be
performed on long-term pain outcomes because of a lack of
studies. GRADE quality of evidence for both long-term pain
outcomes was very low (Table 3).DISCUSSION
This systematic review identiﬁed seven studies, comprising
416 patients, comparing the use of a PNC following lower
limb amputation with either no treatment or placebo con-
trol. Meta-analysis showed that postoperative opioid con-
sumption was reduced by approximately 50% in those
receiving PNC treatment, which was maintained on sensi-
tivity analysis of large and high-quality studies, but was
marginally lost on studies enrolling patients with PAD only.
PNC treatment did not affect postoperative pain scores, in-
hospital mortality, phantom limb pain or stump pain.
Quality of evidence as assessed by the GRADE score was
very low for all outcomes.
Strengths and weaknesses
To date, this is the only systematic review and meta-analysis
to compare the use of a PNC with a control group. An
Table 1. Demographic data and Downs and Black score for included studies.
Author (year) Type of study Retrospective/prospective Number of
centres
Consecutive
patients
Pathology
necessitating
amputation
Patients
(n)
Treatment
group (n)
Control
group (n)
Treatment
group
anaesthetic
Control
group
anaesthetic
Outcomes D&B
score
Ayling
(2014)25
Cohort study Retrospective ND No PAD 198 102 96 ND ND 1,2,3,4,5,6,7 23
Elizaga
(1994)29
Cohort study Retrospective Single ND Neoplastic
pathologies
59 19 40 1,2,3 1,2,3 1,8,9,10 10
Fisher
(1991)26
Quasi-experimental
study
Retrospective ND ND PAD 31 11 20 1 1 1 11
Grant
(2008)27
Quasi-experimental
study
Retrospective Single ND PAD 64 33 31 ND ND 1,3,9 7
Lambert
(2001)15
RCT Prospective ND ND PAD 30 16 14 1 2 1,2,3,9,10 12
Malawer
(1991)19
Case controlled
study
ND ND Yes PAD and
neoplastic
pathologies
13 7 6 ND ND 1 3
Pinzur
(1996)28
RCT Prospective Single No PAD 21 11 10 1,3 1,3 1 19
RCT ¼ randomised controlled trial; ND ¼ no data; PAD ¼ peripheral arterial disease; D&B ¼ Downs and Black.
For anaesthetic used: 1. General anaesthetic, 2. Epidural anaesthetic, 3. Spinal anaesthetic.
For outcomes: 1. Postoperative morphine requirements, 2. Postoperative pain, 3. In-hospital mortality, 4. Postoperative mobilisation (sitting and out of bed), 5. Postoperative delirium, 6.
Postoperative sedation, 7. Postoperative nausea, 8. Length of in-hospital stay, 9. Incidence of long-term phantom limb pain, 10. Incidence of long-term stump pain.
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Table 2. Summary table of outcomes for treatment and control groups.
Sensitivity analysis N studies
(patients)
Treatment
group (n)
Control
group (n)
HG I2
(per cent)
HG p value SMD/OR
(95% CI)
Overall
effect Z
p value
Postoperative opioid use
All studies 7 (416) 199 217 79 <.0001 0.59 (1.10 to 0.07) 2.22 .03
PAD patients only 5 (344) 173 171 85 <.0001 0.66 (1.35 to 0.04) 1.85 .06
Larger studies 3 (321) 154 167 76 .01 0.59 (1.13 to 0.06) 2.18 .03
High quality studies 2 (219) 113 106 0 .45 0.41 (0.67 to 0.14) 2.97 .003
Postoperative pain
All studies 2 (228) 118 110 92 .0006 0.53 (0.93e1.98) 0.71 .48
In-hospital mortality
All studies 2 (262) 135 127 38 .21 0.82 (0.22e3.07) 0.29 .77
Phantom limb pain
All studies 3 (101) 50 51 18 .29 0.49 (0.14e1.76) 1.09 .28
Stump pain
All studies 2 (37) 17 20 0 .73 0.50 (0.11e2.33) 0.89 .37
PNC ¼ perineural catheter; HG ¼ heterogeneity; SMD ¼ standardised mean difference; OR ¼ odds ratio; PAD ¼ peripheral arterial
disease.
246 D.C. Bosanquet et al.extensive review was performed for this analysis and au-
thors were contacted for further information when articles
otherwise suitable for inclusion gave either no, or non-
abstractable data.49,25 The only previous review of the use
of PNCs evaluated pre-emptive analgesia for chronic limb
pain after surgery. Within the review Ypsilantis et al. iden-
tiﬁed three studies utilising a “perineural block,”8 but did
not attempt meta-analysis and included a study comparingFigure 2. Forest plot of treatment versus control group and poa single intraoperative perineural injection of local anaes-
thetic and clonidine versus control.48
However, there were a lack of rigorous randomised trials
available for analysis, with the remaining papers being
generally of low quality. Studies were heterogeneous by
design (RCTversus cohort), control group employed (patients
without PNC versus those with PNC with placebo), and out-
comes measured. Most studies were small (<50 patients),stoperative opioid use; all papers and sensitivity analysis.
Table 3. GRADE analysis and assessment of quality of evidence.
Outcome Starting
quality
Risk of bias Indirectness Inconsistency Imprecision Publication bias Overall quality
of evidence
Postoperative opioid use Low Yes Yes Yes Yes Yes Very low
Postoperative pain Moderate No Yes Yes No Yes Very low
In-hospital mortality Low No Yes No No Yes Very low
Phantom limb pain Low Yes Yes No No Yes Very low
Stump pain Moderate Yes Yes No No Yes Very low
Perineural catheters after lower limb amputations 247and two had signiﬁcant baseline differences between the
cohorts examined.26,28 Quality of included studies, as
assessed by the Downs and Black score, was low. As a result,
GRADE quality of evidence was very low for all outcomes.Explanation of ﬁndings and implications for practice
Despite the quality of evidence analysed, this review sug-
gests that PNC use can reduce postoperative opioid con-
sumption by a factor of around 50%. This is comparable
with other large meta-analyses examining the use of PNCs
for analgesia for many different types of surgery.52 Liu et al.
pooled data from 44 RCTs (2141 patients) undergoing
general, orthopaedic, gynaecological, or cardiothoracic
surgical procedures either with or without a PNC.53 Overall,
PNC use was associated with a signiﬁcant reduction in
postoperative pain scores at rest and movement, opioid
usage, nausea and vomiting, length of hospital stay, and
patient satisfaction.
The recent UK-wide NCEPOD review into lower limb
amputations found that strong opioids were the most
frequently used class of analgesia postoperatively.54 Opioid
analgesia has a well documented adverse event proﬁle,
which is particularly pronounced in the elderly.4 Non-
narcotic analgesia reduces postoperative nausea and vom-
iting,55 constipation,56 sedation and pruritis compared with
opioid analgesia.52 The incidence of delirium may also be
reduced,57 which is an independent variable in predicting
poor outcomes and increased mortality in the elderly.5
Opioid-related side effects increase in-hospital costs by
approximately 7e16% and overall length of stay by
approximately 10%.58,59 Opioid-sparing agents have been
shown to reduce overall inpatient cost compared with
opioid analgesia.60 By contrast, complications from PNCs
are rare, and infective complications occur in no more than
3.2% of patients.61
This analysis found that although PNC reduced opioid use
it had no apparent effect on postoperative pain scores. This
may simply be a reﬂection of the excellent pain relief pro-
vided by the control group analgesic regimen, or a type II
error as a result of the low number of patients evaluated.
The RCT proposed by Borghi et al. comparing postoperative
PNC and opioids, to opioids alone, terminated after the ﬁrst
four patients were randomised, as all controls requested a
PNC because of the apparent improvement in postoperative
pain outcomes.33 A number of case series and reports have
also highlighted the impressive analgesic effect of PNCs,
with some patients requiring no postoperative opioid
analgesia.30,39,40PNC use demonstrated no appreciable effect on either
phantom limb pain or stump pain. This is not surprising
given the complex and poorly understood pathophysiology
of phantom limb pain, of which both peripheral and central
mechanisms may play an important part.62 Amputations
cause massive tissue and neuronal injury,61,62 disrupting the
afferent nerve input to the spinal canal compounded by
central upregulation of norioceptor receptors in the spinal
cord, and cortical reorganisation of the amputated region.63
Although short-term PNC usage may not help, prolonged
(>30 days) PNC treatment has been described with a
relatively low incidence of chronic pain.33
Although impossible to formally measure in meta-
analysis, PNCs are quick and easy to place at the time of
the operation. An elastomeric sphere (the On Demand and
ON-Q PainBuster Post-Op Pain Relief System (I-Flow LLC/
Kimberly Clark)) or automated syringe driver containing a
local anaesthetic of choice can be attached to the end of
the PNC, which delivers a constant rate infusion, with the
option of boluses as required. The cost of the elastomeric
spheres is minimal, at around £25 per patient.
Two RCTs evaluating PNCs are currently recruiting. The
FinAPain-1 study is a multicentre RCT conducted in Finland
of 180 patients comparing 72 h of ropivacaine versus blin-
ded normal saline control in patients undergoing AKA for
PAD, examining postoperative pain, phantom limb pain,
opioid consumption, and adverse events.46 The AMP-study
is a Swedish trial comparing bolused chirocaine via a PNC
following lower limb amputation with a standardised post-
operative epidural regimen in 60 patients.47 Primary
outcome measures are phantom limb pain and sensation,
and secondary outcomes are quality of life, subject well-
being, and depression scores. Although both of these
studies will give further data on which to base clinical
decision-making, neither are expected to complete follow-
up until 2017 and 2016, respectively.
CONCLUSIONS
PNCs appear to reduce postoperative opioid requirements
following lower limb amputation by approximately 50%,
which can reduce the incidence of opioid-related side ef-
fects, without affecting postoperative pain scores, mortality,
phantom limb or long-term stump pain. Although two RCTs
are currently recruiting to further evaluate their efﬁcacy,
neither will report before 2016.
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